ABN AMRO Investment Solutions’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Buy
8,037
+2,061
+34% +$394K 0.02% 435
2026
Q1
$1.1M Buy
5,976
+1,150
+24% +$212K 0.01% 452
2025
Q4
$849K Buy
+4,826
New +$788K 0.01% 435
2024
Q3
Sell
-2,118
Closed -$491K 491
2024
Q2
$491K Buy
+2,118
New +$460K 0.01% 400
2024
Q1
Sell
-14,586
Closed -$3.77M 435
2023
Q4
$3.77M Sell
14,586
-840
-5% -$206K 0.07% 209
2023
Q3
$3.96M Buy
+15,426
New +$4.13M 0.08% 193
2023
Q2
Sell
-1,236
Closed -$344K 410
2023
Q1
$344K Buy
+1,236
New +$342K 0.01% 374

Other funds holding BIIB

ABN AMRO Investment Solutions's BIIB Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its Biogen (BIIB) stake by 34% in Q2 2026, buying an estimated $394K and bringing the position to 8,037 shares worth $1.74M. The position accounts for 0.02% of the portfolio, ranked #435.

ABN AMRO Investment Solutions first reported a position in BIIB in Q1 2023 and has held it in 7 quarters since. The position peaked at $3.96M in Q3 2023. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • ABN AMRO Investment Solutions held 8,037 shares of Biogen worth $1.74M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 2,061 Biogen shares in Q2 2026, an estimated $394K.
  • Biogen made up 0.02% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #435 holding.
  • ABN AMRO Investment Solutions first reported a position in Biogen in Q1 2023 and has held it in 7 quarters since.
  • ABN AMRO Investment Solutions's Biogen position peaked at $3.96M in Q3 2023.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.